How to Register My Medical Device in Philippines: the Six Steps, in the Order You Actually Do Them

How to Register My Medical Device in Philippines: the Six Steps, in Order

Six steps: classify the device, secure a licensed local filer, build the CSDT dossier, submit online, answer the deficiency letter, then keep the certificate alive. Only one of those six sits with the FDA. The other five sit with you and your local entity — which is why slow projects are almost never slow because of the review.

• Step 1 — Classify. A, B, C or D decides whether you notify or fully register, how thick the dossier is, and what anyone can honestly quote you. Get it wrong and everything downstream is rework.
• Step 2 — Find the filer. The applicant is always a company holding a medical-device License to Operate (LTO). Never the product, and never the foreign manufacturer on its own.
• Step 3 — Build the file. A CSDT technical dossier, plus quality-system evidence, a Certificate of Free Sale, a letter of authorization, and legalization of the foreign originals.
• Step 4 — Submit. Through the FDA's online portal, under the licence holder's account: create, upload, pay, and get a transaction reference.
• Step 5 — Deficiencies. A deficiency letter is normal. The response window is short and the number of rounds is usually capped. This is the real exam.
• Step 6 — Certificate and upkeep. It is issued to the entity, it expires, it obliges you to report changes, and it is not a customs release.

This guide stays on the operational side of those six steps. If you still need the groundwork — how the A/B/C/D classes are drawn and how CMDN notification differs from full registration — start with the A/B/C/D risk class overview. If your product is an in-vitro diagnostic, it runs on its own rules: see IVD certification and registration in the Philippines.

Step 1 — Classify the Device Before You Ask Anyone for a Quote

The class governs everything downstream: Class A generally goes through the lighter CMDN notification route, while B, C and D go through full registration — dossier depth, fees and timeline all step up with the letter. So classify before you shop for an agent, not after.

Who does it: your regulatory affairs person drafts the call; the licensed local entity or a consultant reviews it. What it takes: a written intended-use statement, plus the facts that drive the class — is it invasive, is it supplied sterile, how long is the contact, does it deliver energy, does it incorporate a medicinal or animal-derived component, is it used for a measurement that treatment decisions rest on. What you should end up holding: a one-page classification rationale stating which criteria put the device in that class. When someone challenges it later, that page is your defence.

The registration of medical devices in Philippines is organised entirely around that letter, and three mistakes recur:

• Classifying the object instead of the use. The same catheter can sit two classes apart depending on where the labelling says it goes and how long it stays.
• Reading Class A as “exempt”. Class A still needs a licensed entity and still has to be notified before it can be sold legally.
• Reusing last year's answer. Philippine device classification and the scope of mandatory registration keep moving by FDA circular, generally in the direction of more categories requiring full registration, often with transition arrangements. Confirm against the issuance in force on your filing date.

The Philippine framework follows the ASEAN model, so a manufacturer that has already filed elsewhere in ASEAN under CSDT logic will find this step short. A manufacturer holding only EU or US documentation usually has to restructure the file. For the two-layer picture — company-level LTO, then product-level authorization — see FDA product registration in the Philippines.

Step 2 — Registering a Medical Device in Philippines Starts With a Licence You Probably Don't Have

The applicant has to be a Philippine company holding a medical-device License to Operate; a foreign manufacturer cannot file in its own name. So the first problem to solve is not paperwork — it is whose name goes on the application.

Who does it: the local licence holder — importer, distributor, manufacturer or wholesaler, and the licence category has to match what it actually does. What it takes: its valid LTO, its corporate documents, and a letter of authorization from you. Where it stalls:

• Wrong licence category. They have a licence, but it does not cover importation, or does not cover devices. Read the scope printed on the licence itself; do not take it verbally.
• The certificate belongs to them, not to you. Product authorization is issued in the entity's name. If you later want to switch distributors or take the registration in-house and there is no transfer clause agreed up front, you are stuck. This is the single most common long-term trap for foreign manufacturers.
• They won't share the account or the correspondence. The filing lives in their portal account. If you never see the transaction number, you are running the project blind.

Pick a filer on three things: does the licence category cover you, have they filed a device of your class before, and will they give you read access and forward official letters verbatim. Price is the fourth question, not the first.

I Have No Philippine Company — Three Routes, Each With a Price

Three routes: incorporate and get your own LTO; appoint a licensed local distributor as your authorized representative; or park the filing with a licensed service provider, an arrangement the trade calls CPR housing. All three are legitimate. They differ on who owns the certificate and how fast you get in.

• Your own entity with its own LTO. Cleanest long term: the authorization is yours, and changing distributors does not interrupt sales. The cost is time — incorporation, compliant storage or office premises, a qualified person on staff. Best if the Philippines is a long-term market. The company side is covered in registering a company in the Philippines.
• A local distributor as authorized representative. Fastest and cheapest to start, but the registration is tied to your sales channel. That party is simultaneously your route to market and your route to compliance, which puts the leverage on their side. Negotiate transfer, termination and data-ownership terms before you sign, not when the relationship sours.
• CPR housing with a licensed service provider. The middle path: the certificate still is not in your name, but the holder is a neutral compliance provider rather than a competing channel, and is usually far more willing to cooperate on a later transfer. Good as a bridge while your own entity is being set up.

One distinction worth nailing down: an Importer of Record answers “whose name clears the goods”, not “whose name holds the registration”. They can be the same party or different parties, and having an IOR never waives the FDA filing. The difference is set out in the Importer of Record guide.

Practical advice: run incorporation and product filing in parallel. Start filing through a housing arrangement or authorized representative while your own entity is being built, rather than waiting for the company first — waiting turns two overlapping timelines into one long one. If you want that sequencing mapped out before you commit, our product access team can run a feasibility pass on it.

Step 3 — Build the CSDT Dossier the Way the Reviewer Reads It

The core is a CSDT file — the ASEAN Common Submission Dossier Template: device description, intended use, essential principles conformity, design and manufacturing information, risk management, verification and validation, labelling and instructions for use. Every claim printed on the box has to be traceable to evidence inside that file.

Who does it: the technical content comes from the manufacturer's regulatory and quality team; the local entity handles localisation and format compliance. You cannot outsource the technical half — no agency can write your validation data. What else travels with it:

• Quality system evidence — the manufacturer's ISO 13485 certificate or equivalent. Check the expiry date; a lapsed certificate is the same as none.
• Certificate of Free Sale (CFS/CFG) from the country of origin, showing the device is legally sold there.
• Letter of authorization from you to the local entity, with the product scope and validity period matching the application exactly.
• Labelling and IFU, word-for-word consistent with the intended use, model names and manufacturer details inside the dossier.
• Legalization of the foreign originals — notarization plus consular authentication, or an apostille. This is the slowest serial task in the whole project, so start it first. See apostille and authentication for the Philippines.

Where it stalls: files rarely come back because the data was weak. They come back because three things do not match — model names on the label versus in the dossier, a letter of authorization narrower than the products applied for, or a manufacturer name on the CFS that differs from the legal entity on the ISO certificate. Do one line-by-line reconciliation of model names, manufacturer names and intended use before you submit; it routinely saves an entire deficiency round.

Step 4 — Philippines Medical Device Registration: What Submission Actually Looks Like

Filing happens on the FDA's online portal under the licence holder's account: create the application, upload the dossier, pay the assessed amount, and receive a transaction reference — that reference is the only handle you will have for tracking it.

Who does it: the local entity's regulatory staff operate the account. Your job is to supply the documents and to verify that what got uploaded is the final version. Where it stalls:

• Nobody counted the applications. Whether a family of models, sizes or configurations can go in as one application depends on grouping rules — same manufacturer, same intended use, same basic design, and so on. Fees and review are counted per application, so grouping multiplies or divides both your budget and your calendar. Settle it before submission.
• Payment not tied to the application. The payment reference has to be linked to the filing. Money paid but unlinked means the file never enters the queue.
• You never see the reference number. Put it in the agreement: after filing, the entity provides the transaction number and a portal screenshot, and forwards any official correspondence as received — the original letter, not a summary of it.

After submission your only job is to wait for correspondence. What happens inside the agency after that is outside the scope of this guide; this guide's job is to make sure that what you submitted was complete, traceable, and filed under the right name.

Step 5 — The Deficiency Letter Is Where Most Files Die

Getting a deficiency letter is normal, not bad news — but the response window is short and the number of rounds is usually limited, and missing the deadline tends to mean starting over rather than getting an extension. When one lands, everything else moves down the list.

Who does it: the manufacturer's regulatory lead drafts the response; the local entity files it. Do not let the freight forwarder or the sales manager write it — they cannot read what is being asked. What it takes: the original letter, a written point-by-point response, and the revised dossier pages. Where it stalls:

• Responses that are not point-by-point. One item, one answer, each citing the section and page where the fix now lives, so the reviewer never has to hunt.
• Silent edits. Changing something elsewhere in the dossier without flagging it invites a fresh round of questions. List every change in the response.
• The window eaten by internal sign-off. Two weeks disappear getting head-office signatures on a window that was never long. Confirm the deadline the day the letter arrives and work backwards.
• Answering only the easy items. Anything left unanswered comes straight back, and you have burned a round for nothing.

Plan for it: put a deficiency round in the schedule as a certainty, not a risk. What separates a fast project from a slow one is whether the first response takes three days or three weeks.

Step 6 — You Have the Certificate: What It Lets You Do, and What It Doesn't

The certificate authorises the named licence holder to import and sell the listed device. It is not automatically transferable, not open-ended, and not a customs release. Approval is where the obligations start.

• Renewal. The product authorization and the entity's LTO both expire, on two separate clocks. If the licence lapses, your product authorization goes with it. Put both dates in one calendar and start early.
• Variations. A relabelling, a change of manufacturing site, an added model, a revised intended use — these generally have to be notified or applied for. Changing it is not the same as reporting it.
• Post-market duties. Serious adverse events and device malfunctions have to be reported within set timeframes; recalls and field corrective actions have to be executed and documented; advertising and claims are regulated, and unapproved claims are not allowed. These duties sit on the licence holder, who carries them under your authorization — another reason not to choose that partner on price.
• Clearance is a separate exercise. Arriving goods still go through customs formalities; the product certificate is one precondition among several. See Philippine customs clearance, duties and VAT, and which goods need a permit from which agency.

How Long, How Much, and the Three Things I Would Do Differently

Honestly: a clean Class A notification moves relatively quickly, full registration for B, C and D takes considerably longer, and the biggest single variable is not the agency — it is how many deficiency rounds your dossier provokes. Cost is official fees (scaled by class, validity period and number of applications) plus the entity or consultant's service fee; both move with the product and the arrangement. This guide quotes no figures and no day counts on purpose — check the fee schedule and issuances in force when you file.

With hindsight, three things I would change:

• Send the foreign documents for legalization on day one. Notarization, consular authentication or apostille is pure serial waiting time. Every day you delay starting it is a day added to the end of the project.
• Never let the distributor hold the registration by default. Agreements signed during the honeymoon rarely mention transfer. You discover the problem the day you want to change channels and find your market access sitting in someone else's filing cabinet.
• Fix the grouping strategy before accepting a quote. How many models one application covers sets the order of magnitude of the budget. Discovering afterwards that it has to be split into five filings doubles both money and time.

If you would rather have someone sequence classification, entity, dossier and submission into one timeline, our product access team starts with a feasibility review. And if anyone promises approval or a guaranteed decision date, walk — no such guarantee exists.

Disclaimer: this article is general operational guidance and is not legal or regulatory advice. Philippine device classification, filing routes, documentary requirements, fees and timelines can all change by FDA issuance. Rely on the current rules of the Philippine FDA and on professional advice for your specific case.